CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale CFO, Sec'y & Treasurer sold 3,582 shares at an average $1.03 ($3,693)
- 4 Open-market sale Chief Development Officer sold 1,580 shares at an average $1.03 ($1,629)
- 4 Open-market sale Chief Accounting Officer sold 1,725 shares at an average $1.03 ($1,779)
- 4 Open-market sale Chief Accounting Officer sold 1,645 shares at $2.53 ($4,159)
- 4 Open-market sale President & CEO sold 13,634 shares at $2.53 ($34,469)
- 4 Open-market sale Chief Scientific Officer sold 1,686 shares at $2.53 ($4,263)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 3,533 shares at $2.53 ($8,932)
- 4 Open-market sale Chief Development Officer sold 1,549 shares at $2.53 ($3,916)
- 4 Open-market sale Chief Commercial Officer sold 1,673 shares at $2.53 ($4,230)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 1,583 shares at $1.83 ($2,897)
- 4 Open-market sale Chief Accounting Officer sold 1,947 shares at $1.83 ($3,563)
- 4 Open-market sale Chief Scientific Officer sold 2,004 shares at $1.83 ($3,667)
- 4 Open-market sale President & CEO sold 13,278 shares at $1.83 ($24,299)
Page 13 of 17 · 336 filings